Skip to main content

Day: December 28, 2020

COFACE SA : Déclaration des transactions sur actions propres (hors contrat de liquidité) réalisées entre le 21 décembre 2020 et 24 décembre 2020

Paris, le 28 décembre 2020 – 17h45COFACE SA : Déclaration des transactions sur actions propres (hors contrat de liquidité) réalisées entre le 21 décembre 2020 et 24 décembre 2020Conformément au Règlement (UE) No  596/2014 du 16 avril 2014 sur les abus de marché1Les principales caractéristiques du Programme de Rachat d’Actions 2020-2021 ont été publiées sur le site internet de la Société (http://www coface com/fr/Investisseurs/Informations-reglementees dans l’onglet « Transactions sur actions propres ») et elles sont également décrites dans le Document de Référence. Cette information doit être complétée avec le communiqué de presse du 26 octobre 2020.Présentation agrégée par jour et par marchéDétail transaction par transactionCALENDRIER FINANCIER 2020/2021(sous réserve de changements)Résultats 2020 : 10 février 2021, après bourseRésultats...

Continue reading

Karolinska Development’s portfolio company Aprea Therapeutics reports results from Phase 3 study of eprenetapopt in MDS

STOCHOLM, SWEDEN – December 28, 2020. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces today that its portfolio company, Aprea Therapeutics, has reported results from a pivotal Phase 3 study evaluating the efficacy of eprenetapopt in combination with azacitidine (AZA) versus AZA alone in TP53 mutant myelodysplastic syndromes (MDS). The trial failed to meet its primary endpoint of complete remission (CR) rate. Analysis of the primary endpoint at this data cut demonstrated a higher CR rate in the experimental arm receiving eprenetapopt with AZA versus the control arm receiving AZA alone, but did not reach statistical significance.In the intention-to-treat population of 154 patients, the CR rate in the eprenetapopt with AZA arm was 33.3% (95% CI: 23.1% – 44.9%) compared to 22.4% (95% CI: 13.6% – 33.4%) in the AZA...

Continue reading

Karolinska Developments portföljbolag Aprea Therapeutics rapporterar resultat från fas 3-studie av eprenetapopt i MDS

STOCKHOLM, SVERIGE – 28 december 2020. Karolinska Development AB (Nasdaq Stockholm: KDEV) meddelar idag att portföljbolaget Aprea Therapeutics har rapporterat resultat från en registreringsgrundande fas 3-studie av läkemedelskandidaten eprenetapopt i kombination med azacitidin (AZA), jämfört med AZA som singelterapi, i TP53-mutant myelodysplastiskt syndrom (MDS). Studien uppnådde inte det primära målet för fullständig remission (Complete response, CR). Analysen av den primära studieparametern vid denna tidpunkt visade en högre CR-frekvens i de patienter som erhöll eprenetapopt i kombination med AZA jämfört med kontrollarmen som erhöll enbart AZA, men skillnaden var inte statistiskt signifikant.I intention-to-treat-populationen om 154 patienter uppgick CR-frekvensen hos den grupp patienter som erhöll eprenetapopt i kombination med AZA...

Continue reading

El Pollo Loco Says Adiós to 2020 with the Return of Pollo Fit Bowls

COSTA MESA, Calif., Dec. 28, 2020 (GLOBE NEWSWIRE) — El Pollo Loco, Inc. (“El Pollo Loco” or “Company) (Nasdaq: LOCO), the nation’s leading fire-grilled chicken restaurant chain, today announced the return of its fan favorite Pollo Fit Bowls with a delicious twist, just in time to get back to your best self in the new year.Due to the unique circumstances of the global pandemic, 2020 was a year of being more stationary than normal as people sheltered at home. This confinement has led to people to choose unhealthy delivery and take-out options, indulgent comfort food as a quick fix to reduce stress, and a departure from exercise routines that for many have led to the unwanted “Quarantine Bod.” To help say adiós to those unwanted pounds, El Pollo Loco is bringing back its beloved Pollo Fit Bowls, which make it easier for customers...

Continue reading

Evli specifies its outlook for 2020

EVLI BANK PLC STOCK EXCHANGE RELEASE/INSIDE INFORMATION DECEMBER 28, 2020, 5.00 PM. (EET/EEST)During the last quarter of the year the business has developed well. In addition, the general equity and fixed income markets have developed favorably. As a result, the company is specifying its outlook for 2020.Because of the positive development, we estimate our operating profit for 2020 to be above the level of the comparison period.Earlier we estimated that our operating profit for 2020 will be clearly positive. Evli Bank Plc´s Financial Statement Bulletin for 2020 will be released on Friday January 22, 2021.EVLI BANK PLCFor further information:Maunu Lehtimäki, CEO, Evli Bank Plc, tel. +358 (0)50 553 3000, maunu.lehtimaki@evli.comJuho Mikola, CFO, Evli Bank Plc, tel. +358 (0)40 717 8888, juho.mikola@evli.comEvli Bank PlcEvli is a bank specialized...

Continue reading

Evli tarkentaa näkymiään vuodelle 2020

EVLI PANKKI OYJ:N PÖRSSITIEDOTE/SISÄPIIRITIETO 28.12.2020 KLO 17.00 (EET/EEST)Vuoden viimeinen neljännes on sujunut liiketoiminnallisesti hyvin. Lisäksi yleinen osake- ja korkomarkkinoiden kehitys on ollut suotuisaa. Tämän takia yhtiö tarkentaa näkymiään vuodelle 2020.Positiivisen kehityksen seurauksena arviomme vuoden 2020 liikevoiton ylittävän vertailukauden tason.Aiemmin arvioimme vuoden 2020 liikevoiton olevan selvästi positiivinen.Evli Pankin tilinpäätöstiedote vuodelta 2020 julkaistaan perjantaina 22.1.2021.EVLI PANKKI OYJLisätietoja: Maunu Lehtimäki, toimitusjohtaja, Evli Pankki Oyj, p. +358 (0)50 553 3000, maunu.lehtimaki@evli.comJuho Mikola, talousjohtaja, Evli Pankki Oyj, p. +358 (0)40 717 8888, juho.mikola@evli.comEvli Pankki OyjEvli on sijoittamiseen erikoistunut pankki, joka auttaa yhteisöjä, yrityksiä ja yksityishenkilöitä...

Continue reading

Tauriga Sciences Inc. Expands its CBD Infused Skin Care Offerings to Include More Than 10 Different Products

These Product Offerings Include CBD Infused: Face Moisturizer, Anti-Wrinkle Cream, Collagen/Tightening/Detoxifying Face Masks, Lip Balm, Hand & Foot Cream, Transdermal Patch, Massage & Body Oil, Body Spray, and Roll-On Product  NEW YORK, NY, Dec. 28, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with a proprietary line of functional “supplement” chewing gums (Flavors: Pomegranate, Blood Orange, Peach-Lemon, Pear Bellini, Mint, Black Currant) as well as two ongoing Biotechnologies initiatives, today announced that its recently launched Skin Care Offerings have now been expanded to include more than 10 distinct CBD Infused products.  These product offerings include CBD Infused: Face Moisturizer (100mg),...

Continue reading

Changes in substantial shareholding

AS Ekspress Grupp informs about the change in the structure of shareholders with substantial holdings.On 28.12.2020, OÜ HHL Rühm informed AS Ekspress Grupp that as a result of recent transactions, Hans Luik’s indirect holding in AS Ekspress Grupp will increase to a total of 60.28%. During the period from 22nd December to 28th December 2020, OÜ HHL Rühm has acquired 1,096,475 shares of Ekspress Grupp.OÜ HHL Rühm owns 34.42% (10,599,525 shares) and Hans Luik owns 25.86% (7,963,307 shares) of the shares of AS Ekspress Grupp after the transaction on 28 December 2020.Signe KukinGroup CFOAS Ekspress Grupp +372 669 8381signe.kukin@egrupp.eeAS Ekspress Grupp is the leading media group in the Baltic States whose key activities include web media content production, publishing of newspapers and magazines and provision of printing services in Estonia,...

Continue reading

Olulise osaluse muutus

AS Ekspress Grupp teatab muudatusest olulist osalust omavate aktsionäride struktuuris.28.12.2020 informeeris OÜ HHL Rühm ASi Ekspress Grupp, et hiljutiste tehingute tulemusel tõuseb Hans Luige kaudne osalus ASis Ekspress Grupp kokku 60,28%ni. Perioodil 22.-28. detsembrini 2020 on OÜ HHL Rühm omandanud 1 096 475 Ekspress Grupi aktsiat.Peale 28.12.2020 toimunud tehingut kuulub OÜ-le HHL Rühm 34,42% (10 599 525 aktsiat) ja Hans Luigele 25,86% (7 963 307 aktsiat) ASi Ekspress Grupp aktsiatest.Signe KukinKontserni finantsjuhtAS Ekspress Grupp+372 669 8381signe.kukin@egrupp.eeAS Ekspress Grupp on Baltimaade juhtiv meediakontsern, mille tegevus hõlmab veebimeedia sisutootmist, ajalehtede ja ajakirjade kirjastamist ning trükiteenuste osutamist Eestis, Lätis ja Leedus. Samuti haldab kontsern elektroonilist piletimüügiplatvormi ja piletimüügikohti...

Continue reading

Simplicity Esports and Gaming Company Signs Consulting Agreement to Design and Buildout New Esports Gaming Center in Milwaukee, WI

Boca Raton, Florida, Dec. 28, 2020 (GLOBE NEWSWIRE) — Simplicity Esports and Gaming Company (OTCQB:WINR) (“Simplicity Esports”), announced that it has signed a consulting agreement that will generate approximately $250,000 in revenue for planning, designing, and buildout of an esports gaming center at 3130 N Downer Ave in Milwaukee, WI. The owners of the commercial building, directly across the street from University of Wisconsin-Milwaukee contacted Simplicity Esports to leverage the experience of the company with the largest footprint of esports gaming centers in North America, to assist them in the planning and development of their esports gaming center. The gaming center is expected to open to the public during the first calendar quarter of 2021.Roman Franklin, President of Simplicity Esports, stated, “We expect that this is...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.